1 |
Guilbert JJ. 2002. The World Health Report 2002- Reducing risks, promoting healthy life. Education for Health 16: 1-230
|
2 |
Kim DM, Ahn CW, Nam SY. 2005. Prevalence of obesity in Korea. Obes Rev 6: 117-121
DOI
ScienceOn
|
3 |
Pi-Sunyer FX, Becker DM, Bouchard C. 1998. NHLBI obesity education initiative expert panel on the identification, evaluation, and treatment of overweight and obesity in adults. Obes Res 6: 51S-209S
DOI
|
4 |
Kong WJ, Zhang H, Song DQ, Xue R, Zhao W, Wei J, Wang YM, Shan N, Zhou ZX, Yang P, You XF, Li ZR, Si SY, Zhao LX, Pan HN, Jiang JD. 2009. Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression. Metabolism 58: 109-119
DOI
ScienceOn
|
5 |
Huang C, Zhang YB, Gong ZW, Sheng XY, Li ZM, Zhang W, Qin Y. 2006. Berberine inhibits 3T3-L1 adipocyte differentiation through the PPAR gamma pathway. BBRC 348: 571-578
DOI
ScienceOn
|
6 |
Yin J, Gao Z, Liu D, Liu Z, Ye J. 2008. Berberine improves glucose metabolism through induction of glycolysis. Am J Physiol Endocrinol Metab 294: E148-E156
|
7 |
Saltiel AR, Kahn CR. 2001. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414: 799- 806
DOI
ScienceOn
|
8 |
Febbraio M, Abumrad NA, Hajjar DP, Sharma K, Cheng W, Pearce SF, Silverstein RL. 1999. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J Biol Chem 274: 19055-19062
DOI
|
9 |
Ramji DP, Foka P. 2002. CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem J 365: 561-575
DOI
|
10 |
Waldron A. 2007. Obesity and obesity-related complications screening of adults and children in the primary care office. Northeast Florida Medicine 58: 21-24
|
11 |
Grundy SM. 2004. Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab 89: 2595- 2600
DOI
ScienceOn
|
12 |
Tilg H, Moschen AR. 2006. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6: 772-783
DOI
ScienceOn
|
13 |
Anghel SI, Wahli W. 2007. Fat poetry: a kingdom for PPAR gamma. Cell Res 17: 486-511
DOI
ScienceOn
|
14 |
Cooke D, Bloom S. 2006. The obesity pipeline: current strategies in the development of anti-obesity drugs. Nat Rev Drug Discov 5: 919-931
DOI
ScienceOn
|
15 |
Ikram M. 1975. A review on the chemical and pharmacological aspects of genus Berberis. Planta Med 28: 353- 358
DOI
ScienceOn
|
16 |
Subbaiah TV, Amin AH. 1967. Effect of berberine sulphate on Entamoeba histolytica. Nature 215: 527-528
DOI
ScienceOn
|
17 |
Choi BH, Ahn IS, Kim YH, Park JW, Lee SY, Hyun CK, Do MS. 2006. Berberine reduces the expression of adipogenic enzymes and inflammatory molecules of 3T3-L1 adipocyte. Exp Mol Med 38: 599-605
DOI
ScienceOn
|
18 |
Cho IJ, Ahn JY, Kim S, Choi MS, Ha TY. 2008. Resveratrol attenuates the expression of HMG-CoA reductase mRNA in hamsters. BBRC 367: 190-194
DOI
ScienceOn
|
19 |
Zhou JY, Zhou SW, Zhang KB, Tang JL, Guang LX, Ying Y, Xu Y, Zhang L, Li DD. 2008. Chronic effects of berberine on blood, liver glucolipid metabolism and liver PPARs expression in diabetic hyperlipidemic rats. Biol Pharm Bull 31: 1169-1176
DOI
ScienceOn
|
20 |
Unger RH. 2003. Lipid overload and overflow: metabolic trauma and the metabolic syndrome. Trends Endocrinol Metab 14: 398-402
DOI
ScienceOn
|
21 |
Tang J, Feng Y, Tsao S, Wang N, Curtain R, Wang Y. 2009. Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations. J Ethnopharmacol 126: 5-17
DOI
ScienceOn
|
22 |
Olofsson LE, Melander MO, William-Olsson L, Sjostrom KSL, Groop L, Carlsson B, Carlsson LMS, Olsson B. 2008. CCAAT/enhancer binding protein (C/EBP) in adipose tissue regulates genes in lipid and glucose metabolism and a genetic variation in C/EBP is associated with serum levels of triglycerides. J Clin Endocrinol Metab 93: 4880-4886
DOI
ScienceOn
|